4-氰基－2－(三氟甲基)N-乙酰苯胺 | 175277-96-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氰基－2－(三氟甲基)N-乙酰苯胺
• 中文别名: 4-氰基-2-(三氟甲基)乙酰苯胺；4-氰基-2-三氟甲基苯基乙酰胺；4-氰基-2-(三氟甲基)N-乙酰苯胺
• 英文名称: N-(4-cyano-2-(trifluoromethyl)phenyl)acetamide
• 英文别名: 4-acetylamino-3-trifluoromethyl-benzonitrile；4-cyano-2-trifluoromethylacetanilide；N-(4-cyano-2-trifluoromethyl-phenyl)-acetamide；N-[4-cyano-2-(trifluoromethyl)phenyl]acetamide
• CAS: 175277-96-0
• 化学式: C₁₀H₇F₃N₂O
• mdl: MFCD00052844
• 分子量: 228.174
• InChiKey: OBFBGHKUUCGSPC-UHFFFAOYSA-N

物化性质

• 熔点：
  169 °C

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  52.9
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R20/21/22
• 危险类别：
  IRRITANT
• 安全说明：
  S26,S36

SDS

Name:	N1-[4-Cyano-2-(trifluoromethyl)phenyl]acetamide 97% Material Safety Data Sheet
Synonym:	2-Acetamido-5-cyanobenzotrifluorid
CAS:	175277-96-0

Section 1 - Chemical Product MSDS Name:N1-[4-Cyano-2-(trifluoromethyl)phenyl]acetamide 97% Material Safety Data Sheet
Synonym:2-Acetamido-5-cyanobenzotrifluorid

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
175277-96-0	N1-[4-Cyano-2-(trifluoromethyl)phenyl]	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 175277-96-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 169 - 171 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H7F3N2O
Molecular Weight: 228

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, acids, bases.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 175277-96-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N1-[4-Cyano-2-(trifluoromethyl)phenyl]acetamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 175277-96-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 175277-96-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 175277-96-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氰基－2－(三氟甲基)N-乙酰苯胺 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 5.0h， 以78%的产率得到4-氨基-3-三氟甲基苯甲酸
  参考文献：
  名称：

  Kruger; Keck; Noll, Arzneimittel-Forschung/Drug Research, 1984, vol. 34, # 11 A, p. 1612 - 1624

  摘要：

  DOI：
• 作为产物：
  描述：

  邻氨基三氟甲苯 在 碘 、 calcium carbonate 作用下， 以 甲醇 、 六甲基磷酰三胺 、 水 、 甲苯 为溶剂， 反应 32.0h， 生成 4-氰基－2－(三氟甲基)N-乙酰苯胺
  参考文献：
  名称：

  Kruger; Keck; Noll, Arzneimittel-Forschung/Drug Research, 1984, vol. 34, # 11 A, p. 1612 - 1624

  摘要：

  DOI：

文献信息

• [DE] AUSGEWÄHLTE CGRP-ANTAGONISTEN, VERFAHREN ZU DEREN HERSTELLUNG SOWIE DEREN VERWENDUNG ALS ARZNEIMITTEL<br/>[EN] SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT<br/>[FR] ANTAGONISTES DU CGRP SELECTIONNES, PROCEDES DE PRODUCTION ET D'UTILISATION COMME MEDICAMENTS DESDITS ANTAGONISTES
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2004037810A1

  公开（公告）日：2004-05-06

  Gegenstand der vorliegenden Erfindung sind die CGRP-Antagonisten der allgemeinen Formel (I), in der A, U, V, W, X und R1 bis R 3 wie in Anspruch 1 definiert sind, deren Tautomere, deren Diastereomere, deren Enantiomere, deren Hydrate, deren Gemische und deren Salze sowie die Hydrate der Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.

  本发明的对象是CGRP拮抗剂的一般公式（I）中的CGRP拮抗剂，其中A、U、V、W、X和R1至R3如权利要求1中定义，其互变异构体，其对映异构体，其差向异构体，其水合物，其混合物及其盐以及盐的水合物，尤其是其与无机或有机酸形成的生理耐受盐，含有这些化合物的药物，其用途以及其制备方法。
• Visible-light-induced Pd-catalyzed <i>ortho</i>-trifluoromethylation of acetanilides with CF₃SO₂Na under ambient conditions in the absence of an external photocatalyst
  作者：Long Zou、Pinhua Li、Bin Wang、Lei Wang

  DOI：10.1039/c9cc01014a

  日期：——

  A visible-light-induced Pd-catalyzed ortho-trifluoromethylation of acetanilides with CF₃SO₂Na without any external photocatalyst or additive was developed.

  使用可见光诱导的Pd催化剂对乙酰苯胺进行CF₃SO₂Na的ortho-三氟甲基化反应，无需任何外部光催化剂或添加剂。
• Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
  申请人：Rudolf Klaus

  公开号：US20060079504A1

  公开（公告）日：2006-04-13

  The present invention relates to CGRP antagonists of general formula wherein A, U, V, W, X and R 1 to R 3 are defined as in claim 1, the tautomers, diastereomers, enantiomers, hydrates, mixtures thereof and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them.

  本发明涉及通式为A、U、V、W、X和R1至R3如权利要求1所定义的CGRP拮抗剂，其互变异构体、对映异构体、立体异构体、水合物、混合物及其盐，以及与无机或有机酸形成的盐的水合物，特别是其生理上可接受的盐，以及含有这些化合物的药物组合物，其用途和制备它们的过程。
• Copper-Free Direct C–H Trifluoromethylation of Acetanilides with Sodium Trifluoromethanesulfinate
  作者：Mingxi Wu、Xinfei Ji、Wenpeng Dai、Song Cao

  DOI：10.1021/jo501221h

  日期：2014.10.3

  A copper-free direct C-H ortho trifluoromethylation of electron-deficient 4-substituted acetanilides using Langlois reagent (NaSO2CF3) as the CF3 source in the presence of tert-butyl hydroperoxide (tBuOOH, TBHP) was developed.
• KRUEGER, G.;KECK, J.;NOLL, K.;PIEPER, H., ARZNEIM.-FORSCH., 1984, 34, N 11A, 1612-1624
  作者：KRUEGER, G.、KECK, J.、NOLL, K.、PIEPER, H.

  DOI：——

  日期：——